{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T08:28:02Z","timestamp":1775896082538,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN261200800001E"],"award-info":[{"award-number":["HHSN261200800001E"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015015","name":"Government of South Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","bbmt.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.bbmt.2019.04.008","type":"journal-article","created":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T15:42:01Z","timestamp":1555083721000},"page":"1666-1673","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Outcomes of Related and Unrelated Donor Searches Among Patients with Primary Immunodeficiency Diseases Referred for Allogeneic Hematopoietic Cell Transplantation"],"prefix":"10.1016","volume":"25","author":[{"given":"Mary Joseph","family":"Acevedo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer S.","family":"Wilder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joie","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corin","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dianne","family":"Hilligoss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bazetta","family":"Blacklock-Schuver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth M.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy P.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher G.","family":"Kanakry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimana","family":"Dimitrova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer A.","family":"Kanakry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bbmt.2019.04.008_bib0001","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1537-2995.2006.00842.x","article-title":"The National Marrow Donor Program with emphasis on the early years","volume":"46","author":"McCullough","year":"2006","journal-title":"Transfusion"},{"issue":"24","key":"10.1016\/j.bbmt.2019.04.008_bib0002","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1056\/NEJMoa0904971","article-title":"Allogeneic hematopoietic stem-cell transplantation for sickle cell disease","volume":"361","author":"Hsieh","year":"2009","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.bbmt.2019.04.008_bib0003","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry","volume":"371","author":"Gragert","year":"2014","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.bbmt.2019.04.008_bib0004","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1182\/bloodadvances.2018021899","article-title":"Is a matched unrelated donor search needed for all allogeneic transplant candidates?","volume":"2","author":"Ciurea","year":"2018","journal-title":"Blood Adv"},{"issue":"8","key":"10.1016\/j.bbmt.2019.04.008_bib0005","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.bbmt.2008.06.005","article-title":"Paucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor options","volume":"14","author":"Dew","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.bbmt.2019.04.008_bib0006","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1182\/blood-2002-08-2510","article-title":"Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood?","volume":"101","author":"Grewal","year":"2003","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bbmt.2019.04.008_bib0007","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.bbmt.2016.07.022","article-title":"HapLogic: a predictive human leukocyte antigen-matching algorithm to enhance rapid identification of the optimal unrelated hematopoietic stem cell sources for transplantation","volume":"22","author":"Dehn","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.bbmt.2019.04.008_bib0008","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.bbmt.2017.12.791","article-title":"Validation of an algorithm to predict the likelihood of an 8\/8 HLA-matched unrelated donor at search initiation","volume":"24","author":"Davis","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.bbmt.2019.04.008_bib0009","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.bbmt.2019.04.008_bib0010","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/bmt.2008.203","article-title":"Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases","volume":"42","author":"Brodsky","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.bbmt.2019.04.008_bib0011","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nrclinonc.2015.128","article-title":"Modern approaches to HLA-haploidentical blood or marrow transplantation","volume":"13","author":"Kanakry","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"10.1016\/j.bbmt.2019.04.008_bib0012","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bbmt.2018.02.006","article-title":"Development of an unrelated donor selection score predictive of survival after HCT: donor age matters most","volume":"24","author":"Shaw","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bbmt.2019.04.008_bib0013","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/blood-2015-08-663823","article-title":"The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy","volume":"127","author":"Kollman","year":"2016","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.bbmt.2019.04.008_bib0014","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/bmt.2013.14","article-title":"Donor choice according to age for allo-SCT for AML in complete remission","volume":"48","author":"Ayuk","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.bbmt.2019.04.008_bib0015","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/leu.2012.210","article-title":"Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings","volume":"27","author":"Kroger","year":"2013","journal-title":"Leukemia"},{"issue":"26","key":"10.1016\/j.bbmt.2019.04.008_bib0016","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.bbmt.2019.04.008_bib0017","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1371\/journal.pbio.0050201","article-title":"Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation","volume":"5","author":"Chambers","year":"2007","journal-title":"PLoS Biol"},{"issue":"5","key":"10.1016\/j.bbmt.2019.04.008_bib0018","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.bbmt.2018.02.005","article-title":"Haploidentical bone marrow transplantation with post-transplant cyclophosphamide using non-first-degree related donors","volume":"24","author":"Elmariah","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.bbmt.2019.04.008_bib0019","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/bloodadvances.2017014829","article-title":"Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide","volume":"2","author":"McCurdy","year":"2018","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.bbmt.2019.04.008_bib0020","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jaci.2016.03.016","article-title":"Adenosine deaminase type 2 deficiency masquerading as GATA2 deficiency: successful hematopoietic stem cell transplantation","volume":"138","author":"Hsu","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.bbmt.2019.04.008_bib0021","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10875-018-0525-8","article-title":"Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment","volume":"38","author":"Meyts","year":"2018","journal-title":"J Clin Immunol"},{"issue":"7","key":"10.1016\/j.bbmt.2019.04.008_bib0022","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/s41431-018-0130-6","article-title":"A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centre's experience","volume":"26","author":"Rama","year":"2018","journal-title":"Eur J Hum Genet"},{"issue":"10","key":"10.1016\/j.bbmt.2019.04.008_bib0023","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1136\/annrheumdis-2016-210802","article-title":"ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study","volume":"76","author":"Caorsi","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.bbmt.2019.04.008_bib0024","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2249.2007.03321.x","article-title":"Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: incidence and autoimmune serology","volume":"148","author":"Cale","year":"2007","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.bbmt.2019.04.008_bib0025","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2133.1989.tb01434.x","article-title":"Dermatoses in five related female carriers of X-linked chronic granulomatous disease","volume":"121","author":"Garioch","year":"1989","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.bbmt.2019.04.008_bib0026","first-page":"184","article-title":"Lupus erythematosus tumidus and chronic discoid lupus erythematosus in carriers of X-linked chronic granulomatous disease","volume":"10","author":"Rupec","year":"2000","journal-title":"Eur J Dermatol"},{"issue":"9","key":"10.1016\/j.bbmt.2019.04.008_bib0027","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00251-005-0036-7","article-title":"Polymorphism of the mouse gene for the interleukin 10 receptor alpha chain (Il10ra) and its association with the autoimmune phenotype","volume":"57","author":"Qi","year":"2005","journal-title":"Immunogenetics"},{"issue":"17","key":"10.1016\/j.bbmt.2019.04.008_bib0028","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1182\/blood-2017-03-772392","article-title":"At least 20% donor myeloid chimerism is necessary to reverse the sickle phenotype after allogeneic HSCT","volume":"130","author":"Fitzhugh","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.04.008_bib0029","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1196\/annals.1345.061","article-title":"Murine and math models for the level of stable mixed chimerism to cure beta-thalassemia by nonmyeloablative bone marrow transplantation","volume":"1054","author":"Roberts","year":"2005","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.bbmt.2019.04.008_bib0030","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bbmt.2009.11.011","article-title":"Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome","volume":"16","author":"Kasamon","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bbmt.2019.04.008_bib0031","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.bbmt.2017.10.023","article-title":"Grade II acute graft-versus-host disease and higher nucleated cell graft dose improve progression-free survival after HLA-haploidentical transplant with post-transplant cyclophosphamide","volume":"24","author":"McCurdy","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.bbmt.2019.04.008_bib0032","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.bbmt.2013.01.016","article-title":"Partially mismatched transplantation and human leukocyte antigen donor-specific antibodies","volume":"19","author":"Gladstone","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.bbmt.2019.04.008_bib0033","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.ymthe.2017.03.018","article-title":"Evolving gene therapy in primary immunodeficiency","volume":"25","author":"Thrasher","year":"2017","journal-title":"Mol Ther"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119302319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119302319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T20:41:18Z","timestamp":1738010478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879119302319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1083879119302319"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.04.008","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of Related and Unrelated Donor Searches Among Patients with Primary Immunodeficiency Diseases Referred for Allogeneic Hematopoietic Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}